According to Nurix Therapeutics latest financial reports the company has an operating margin of -2.01%, an decrease of -57.69% to 2022. At the end of 2022 company had an operating margin of -4.76%.
Year | Operating Margin | Change |
---|---|---|
2023 | -2.01% | -57.69% |
2022 | -4.76% | 20.13% |
2021 | -3.96% | 8.66% |
2020 | -3.65% | - |